Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: Which to choose?

Pediatric Transplantation

Volumn 9, Issue SUPPL. 7, 2005, Pages 37-47

  Elfenbein, Gerald J ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Blood; Engraftment; Marrow; Stem cells; Transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD; CONFERENCE PAPER; HEMATOPOIETIC CELL; HUMAN; ISOGRAFT; STEM CELL TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHILD; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 28344441730     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00444.x     Document Type: Conference Paper

References (29)

1. OSGOOD EE, RIDLE M, MATHEWS T. Aplastic anemia treated with daily transfusions and intravenous marrow: a case report. Ann Int Med 1939: 13: 357-367.
2. THOMAS ED. LOCHTE HL Jr, LU WC, FERREBEE JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957: 12: 491-496.
3. KURNICK NB, MONTANO A, GERDES JC, FEDER BH. Preliminary observations on treatment of post irradiation hematopoietic depression in man by infusion of stored autogenous bone marrow. Ann Int Med 1958: 49: 973-987.
4. THOMAS ED, LOCHTE Jr HL, CANNON JH, SAHLER OD, FERREBEE JW. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 1959: 38: 1709-1716.
5. MCGOVERN JJ Jr, RUSSELL PS, ATKINS L, WEBSTER EW. Treatment of terminal leukemic relapse by total-body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission. N Engl J Med 1959: 260: 675-683.
6. ATKINSON JB, MAHONEY FJ, SCHWARTZ IR, HESCH JA. Therapy of acute leukemia by whole-body irradiation and bone marrow transplantation from an identical normal twin. Blood 1959: 14: 228-234.
7. ROBINS MM, NOYES WD. Aplastic anemia treated with bone-marrow transfusion from an identical twin. N Eng J Med 1961 : 265: 974-979.
8. MATHÊ G, AMIEL JL, SCHWARZENBERG L, et al. Successful allogeneic bone marrow transplantation in man: chimerism induced specific tolerance and possible anti-leukemic effects. Blood 1965: 25: 179-196.
9. KÖRBLING M, BURKE P, BRAINE HG, ELFENBEIN GJ, SANTOS GW, KAIZER H. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol 1981: 9: 684-690.
10. EPSTEIN RB, GRAHAM TC, BUCKNER CD, BRYANT J, THOMAS ED. Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. Blood 1966: 28: 692-707.
11. CALVO W, FLIEDNER TM, HERBST E, HUGL E, BRUCH C. Regeneration of blood-forming organs after autologous leukocyte transfusion in lethally irradiated dogs. II. Distribution and cellularity of the marrow in irradiated and transfused animals. Blood 1976: 47: 593-601.
12. KESSINGER A, ARMITAGE JO, LANDMARK JD, SMITH DM, WEISENBURGER DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988: 71: 723-727.
13. ELFENBEIN GJ. Clinical factors contributing to the pace of engraftment after allogeneic and autologous stem cell transplantation: multivariate analyses. In: ABRAHAM NG, TABILIO A, MARTELLI M, ASANO S. DONFRANSCO A, eds. Molecular Biology of Hematopoiesis 6, vol. 6. New York: Plenum Publishing, pp. 103-111.
14. ELFENBEIN GJ, JANSSEN WE, PERKINS JB, PARTYKA JS, FIELDS KK. Mathematical modeling of human hematopoiesis: lessons learned from the bedside following autologous peripheral blood stem cell transplants. In: DICKE KA, KEATING A, eds. Autologous Marrow and Blood Transplantation, Proceedings of the 8th International Symposium, vol. 8. Charlottesville, Virginia: Garden Jennings, pp. 443-466.
15. ISOLA LM, SCIGLIANO E, SKERRETT D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997: 20: 1033-1037.
16. SERODY JS, SPARKS SD, LIN Y, et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000: 6: 434-440.
17. MORTON J, HUTCHINS C, DURRANT S. Granulocyte-colony-stimulating factor (G-CSF) primed allogeneic bone marrow: Significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001: 98: 3186-3191.
18. JI S-Q, CHEN H-R, WANG H-X, YAN H-M, PAN SP, XUN CQ. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 2002: 8: 261-267.
19. ELFENBEIN GJ, SACKSTEIN R, OBLON DJ. Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No! blood cells. Mol Dis 2004: 32: 106-111.
20. JANSSEN WE, ELFENBEIN GJ. Mobilization of peripheral blood stem cells: are all regimens created equal? In: LEVITT D, MERTELSMANN R, eds. Hematopoietic Stem Cells: Biology and Therapeutic Applications. New York: Marcel Dekker, pp. 403-419.
21. ELFENBEIN GJ, SACKSTEIN R. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady state bone marrow. Exp Hematol 2004: 32: 327-339.
22. STEVENS CE, SCARADAVOU A, RUBINSTEIN P. Does age affect outcome in cord blood transplants? Retrospective analysis of 1101 transplants from the New York Blood Center's National Cord Blood Program (abstract). Blood 2002: 100: 641a (Abstract 2522).
23. JANSSEN WE, ELFENBEIN GJ, PERKINS JB, et al. Final report of the first prospective, stratified, randomized trial comparing G-CSF primed bone marrow cells with G-CSF mobilized peripheral blood cells for pace of hematopoietic engraftment and disease free survival after high dose therapy and autotransplant. In: DICKE KA, KEATING A, eds. Autologous Blood and Marrow Transplantation, Proceedings of the 9th International Symposium, vol. 9. Charlottesville, Virginia: Garden Jennings, 1999: pp. 580-598.
24. ELFENBEIN G, MALIK S, PECORA A, et al. Engraftment after high dose therapy for lymphoma with low doses of CD34 + peripheral blood stem cells and ex vivo expanded bone marrow cells. In: DICKE KA, KEATING A, eds. Autologous Blood and Marrow Transplantation, Proceedings of the 10th International Symposium, vol. 10. Charlottesville, Virginia: Garden Jennings, pp. 590-596.
25. ELFENBEIN G, LUM L, RATHORE R, et al. Engraftment potential of marrow harvested after chemo-growth factor mobilized blood collection. Exp Hematol 2003: 31: 114.
26. HAIOUN C, LEPAGE E, GISSELBRECHT C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1994: 12: 2524-2526.
27. HAIOUN C, LEPAGE E, GISSELBRECHT C, et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997: 15: 1131-1137.
28. HAIOUN C, LEPAGE E, GISSELBRECHT C, et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol - a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol 2000: 18: 3025-3030.
29. STORB R, DONEY KC, THOMAS ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 1982: 59: 236-246.